0      0

29th Napa Pain Conference Posters

Acute and chronic stimulation with the Injectrode transcutaneously and through interconnectable implantable waveform generators


Trial leads are used to evaluate response to neuromodulation therapies prior to a definitive implantation. After the trial period, currently available leads require removal and replacement with a permanent lead. Unfortunately, successful trials are often followed by inefficacious permanent implants, potentially due to positional placement sensitivity and/or scar tissue at the implant site. To address this issue, we developed the fully needle-implanted InjectrodeⓇ which facilitates a trial period, followed by a straightforward conversion to chronic therapy through either: 1) augmented transcutaneous stimulation, or 2) attachment to implanted pulse generators as demonstrated here in a rodent sciatic nerve model.


You must be logged in and own this session in order to post comments.